UK markets closed

KemPharm Inc (1GDA.DU)

Dusseldorf - Dusseldorf Delayed price. Currency in EUR
Add to watchlist
4.30000.0000 (0.00%)
As of 07:30PM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
16,563
-
10,161
28,650
13,288
12,839
Cost of revenue
1,089
-
222
2,059
1,305
2,945
Gross profit
15,474
-
9,939
26,591
11,983
9,894
Operating expenses
Research development
34,926
-
19,803
10,161
8,843
19,415
Selling general and administrative
24,734
-
15,038
8,701
7,921
10,816
Total operating expenses
59,660
-
34,841
18,862
16,764
30,231
Operating income or loss
-44,186
-
-24,902
7,729
-4,781
-20,337
Interest expense
915
-
335
376
7,090
6,514
Total other income/expenses net
541
-
-3,081
-16,135
-1,012
1,998
Income before tax
-39,951
-
-26,805
-8,521
-12,794
-24,544
Income tax expense
-34
-
-33
34
-34
-22
Income from continuing operations
-39,917
-
-26,772
-8,555
-12,760
-24,522
Net income
-39,917
-
-26,772
-8,555
-12,760
-24,522
Net income available to common shareholders
-39,917
-
-26,772
-62,897
-12,760
-24,522
Basic EPS
-1.16
-1.30
-0.78
-2.11
-3.21
-
Diluted EPS
-1.16
-1.30
-0.78
-2.11
-3.21
-
Basic average shares
34,400
35,452
34,489
29,766
3,981
-
Diluted average shares
36,212
35,452
34,489
29,766
3,981
-